ES2136291T3 - Derivados de pirimidina. - Google Patents
Derivados de pirimidina.Info
- Publication number
- ES2136291T3 ES2136291T3 ES95918728T ES95918728T ES2136291T3 ES 2136291 T3 ES2136291 T3 ES 2136291T3 ES 95918728 T ES95918728 T ES 95918728T ES 95918728 T ES95918728 T ES 95918728T ES 2136291 T3 ES2136291 T3 ES 2136291T3
- Authority
- ES
- Spain
- Prior art keywords
- sup
- sub
- similar
- alkyl group
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/58—Two sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
DERIVADOS DE PIRIMIDINA UTILES COMO AGENTE PROQUINETICO GASTROINTESTINAL, REPRESENTADO POR LA FORMULA (I) DONDE X ES O O NR{SUP,5}, Y ES O, S O NR{SUP,5} DONDE R{SUP,5} ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO C{SUB,1}-C{SUB,6} O SIMILAR; R{SUP,1} Y R{SUP,2} PUEDEN SER IGUALES O DISTINTOS Y PUEDEN SER UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO C{SUB,1}-C{SUB,6} O SIMILAR; R{SUP,3} ES CN, O COOR{SUP,6} DONDE R{SUP,6} ES UN GRUPO ALQUILO C{SUB,1}-C{SUB,6}, UN GRUPO CICLOALQUILO C{SUB,3}-C{SUB,6}, UN GRUPO ARILO O SIMILAR; R{SUP,4} ES -SR{SUP,7} O -NR{SUP,8}R{SUP,9} DONDE R{SUP,7} ES UN GRUPO ALQUILO C{SUB,1}-C{SUB,6}; R{SUP,8} ES UN GRUPO ALQUILO C{SUB,1}-C{SUB,6} O SIMILAR; R{SUP,9} ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO C{SUB,1}C{SUB,6} O SIMILAR, O R{SUP,8} Y R{SUP,9} PUEDEN REPRESENTAR, JUNTO CON EL ATOMO DE NITROGENO AL CUAL ESTAN UNIDOS, UN ANILLO DE PIPERAZINA N-SUSTITUIDA DE FORMULA (X) DONDE R{SUP,10} REPRESENTA UN GRUPO ALQUILO C{SUB,1}-C{SUB,6} O SIMILAR ASI COMO LAS SALES FARMACEUTICAMENTE ACEPTABLES. LOS COMPUESTOS ARRIBAS MENCIONADOS SON UTILES COMO AGENTE PROCINETICO GASTROINTESTINAL UTILIZADO EN LA TERAPIA DE LAS ENFERMEDADES DEL TRACTO DIGESTIVO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12716194 | 1994-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2136291T3 true ES2136291T3 (es) | 1999-11-16 |
Family
ID=14953157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95918728T Expired - Lifetime ES2136291T3 (es) | 1994-05-18 | 1995-05-17 | Derivados de pirimidina. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5736550A (es) |
EP (1) | EP0760368B1 (es) |
KR (1) | KR970703324A (es) |
BR (1) | BR9507666A (es) |
CA (1) | CA2189963A1 (es) |
DE (1) | DE69511086T2 (es) |
ES (1) | ES2136291T3 (es) |
TW (1) | TW298591B (es) |
WO (1) | WO1995031442A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5567718A (en) * | 1994-08-11 | 1996-10-22 | Hoechst Marion Roussel Inc. | 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors |
US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
CN1198803C (zh) * | 1999-03-05 | 2005-04-27 | 第一三得利制药株式会社 | 具有激活烟碱性乙酰胆碱α4β2受体作用的杂环化合物 |
WO2000063168A1 (en) * | 1999-04-16 | 2000-10-26 | Coelacanth Chemical Corporation | Synthesis of azetidine derivatives |
US6451806B2 (en) | 1999-09-29 | 2002-09-17 | Adolor Corporation | Methods and compositions involving opioids and antagonists thereof |
US6469030B2 (en) | 1999-11-29 | 2002-10-22 | Adolor Corporation | Methods for the treatment and prevention of ileus |
CA2423251A1 (en) * | 2000-09-29 | 2002-04-04 | Glaxo Group Limited | Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
EP1354882A1 (en) * | 2000-12-27 | 2003-10-22 | Kyowa Hakko Kogyo Co., Ltd. | Dipeptidyl peptidase iv inhibitor |
GB0207447D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
GB0218260D0 (en) * | 2002-08-06 | 2002-09-11 | Charterhouse Therapeutics Ltd | Improvements in pharmaceutically useful compounds |
WO2006020070A2 (en) * | 2004-07-16 | 2006-02-23 | Teva Pharmaceutical Industries, Ltd. | Indanylamino uracils and their use as antioxidants and neuroprotectants |
DE102004049728A1 (de) * | 2004-10-11 | 2006-04-13 | Merck Patent Gmbh | Verfahren zur Herstellung von monosubstituierten Piperazinderivaten |
CN101230059B (zh) * | 2007-01-23 | 2011-08-17 | 上海恒瑞医药有限公司 | 双环氮杂烷类衍生物、其制备方法及其在医药上的用途 |
CN101230058A (zh) * | 2007-01-23 | 2008-07-30 | 上海恒瑞医药有限公司 | 双环氮杂烷类衍生物、其制备方法及其在医药上的用途 |
MX2010008049A (es) | 2008-01-23 | 2010-11-12 | Jiangsu Hansoh Pharmaceutical Co Ltd | Derivados de dicicloazaalcano, sus procesos de preparacion y usos medicos. |
CN102838609B (zh) * | 2012-08-27 | 2014-12-24 | 华东师范大学 | 一种氮杂双环[3.3.0]辛烷衍生物及其制备方法和应用 |
CN103012318B (zh) * | 2012-11-25 | 2014-12-10 | 大理学院 | 氟苄基取代哌嗪类化合物及其制备和医药用途 |
CN104961646B (zh) * | 2015-02-17 | 2017-02-22 | 沈阳药科大学 | 莫沙必利的活性代谢物及其制备方法和用途 |
WO2017185261A1 (zh) * | 2016-04-27 | 2017-11-02 | 沈阳药科大学 | 莫沙必利的活性代谢物及其制备方法和用途 |
EP3526199B1 (en) * | 2016-10-14 | 2022-04-13 | Tes Pharma S.r.l. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE229403C (es) * | ||||
DE224032C (es) * | ||||
DE3205638A1 (de) * | 1982-02-17 | 1983-08-25 | Hoechst Ag, 6230 Frankfurt | Trisubstituierte pyrimidin-5-carbonsaeuren und deren derivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel |
DD224032A1 (de) * | 1984-05-17 | 1985-06-26 | Adw Ddr | Verfahren zur herstellung von neuen polyfunktionell substituierten pyrimidin-2-onen |
DD229403A1 (de) * | 1984-11-30 | 1985-11-06 | Akad Wissenschaften Ddr | Verfahren zur herstellung von 6-amino-substituierten und kondensierten pyrimidin-2,4-dionen |
DK167280B1 (da) * | 1985-03-20 | 1993-10-04 | Ciba Geigy Ag | 3-aryluracilderivater, fremgangsmaade til fremstilling deraf, ukrudtsbekaempelsesmidler indeholdende disse derivater samt anvendelsen af derivaterne til ukrudtsbekaempelse |
-
1995
- 1995-05-17 CA CA002189963A patent/CA2189963A1/en not_active Abandoned
- 1995-05-17 BR BR9507666A patent/BR9507666A/pt not_active Application Discontinuation
- 1995-05-17 US US08/737,335 patent/US5736550A/en not_active Expired - Fee Related
- 1995-05-17 EP EP95918728A patent/EP0760368B1/en not_active Expired - Lifetime
- 1995-05-17 ES ES95918728T patent/ES2136291T3/es not_active Expired - Lifetime
- 1995-05-17 DE DE69511086T patent/DE69511086T2/de not_active Expired - Fee Related
- 1995-05-17 KR KR1019960706565A patent/KR970703324A/ko not_active Application Discontinuation
- 1995-05-17 WO PCT/JP1995/000937 patent/WO1995031442A1/ja active IP Right Grant
- 1995-05-17 TW TW084104876A patent/TW298591B/zh active
Also Published As
Publication number | Publication date |
---|---|
TW298591B (es) | 1997-02-21 |
KR970703324A (ko) | 1997-07-03 |
EP0760368A4 (en) | 1997-08-27 |
US5736550A (en) | 1998-04-07 |
BR9507666A (pt) | 1997-09-23 |
EP0760368B1 (en) | 1999-07-28 |
CA2189963A1 (en) | 1995-11-23 |
DE69511086D1 (en) | 1999-09-02 |
DE69511086T2 (de) | 2000-01-05 |
WO1995031442A1 (en) | 1995-11-23 |
EP0760368A1 (en) | 1997-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2136291T3 (es) | Derivados de pirimidina. | |
SE8102193L (sv) | Terapeutiskt aktiv organisk forening och dess anvendning | |
ATE448226T1 (de) | Aza heterocyclische derivate und ihre therapeutische verwendung | |
MX9307940A (es) | Nuevos derivados de la imidazopiridina, proceso para su preparacion y formulaciones farmaceuticas que los incluyen | |
MY101208A (en) | Phenyl-piperazine anti-arrhythmia agents. | |
ES2081966T3 (es) | Derivados heterociclicos benzocondensados que contienen n. | |
ES2164889T3 (es) | Semicarbazonas con actividad sobre el snc y preparados farmaceuticos a base de las mismas. | |
ES2174064T3 (es) | Derivados de 1,3 - dihidro - 1 - (fenilalquil) - 2h - imidazol - 2 - ona que presentan una actividad frente a pde iv y a citoquinas. | |
ES2084339T3 (es) | Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central. | |
ATE239732T1 (de) | Indol-derivat, verfahren zu dessen herstellung und dessen medizinische anwendung | |
NO304486B1 (no) | Oksazolidonderivater og anvendelser derav, og midler og medisinske preparater omfattende slike oksazolidonderivater | |
NO885655L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-methylpyrrolidin- og fucitolderivater. | |
NO852514L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido (5,4-d) pyrimidin-derivater. | |
NO873189L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido (2,3-b)(1,4)benzodiazepin-6-on-derivater. | |
DE3862791D1 (de) | N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel. | |
ATE56436T1 (de) | Diselenobisbenzoesaeureamide primaerer heterocyclischer amine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE169015T1 (de) | Aminobenzoesäure derivate | |
DE69315363D1 (de) | Amphotere tricyclische Verbindungen als antihistaminische und antiallergische Mittel | |
ES2054186T3 (es) | Composicion antihepatopatica. | |
ES2147316T3 (es) | 1-cicloalqueniltetrazolinonas. | |
ATE29877T1 (de) | Mittel zur senkung der herzfrequenz. | |
HU913293D0 (en) | Process for the production of pierazine derivatives and medical preparations containing them | |
DE3782235D1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
ATE95697T1 (de) | Uricosuretische zusammensetzung. | |
SE8702697D0 (sv) | Method of treating ischaemic vascular diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 760368 Country of ref document: ES |